A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
NCT04508907
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Kidney Transplant; Complications
Heart Transplant Infection
Interventions
DRUG:
Mavyret
Sponsor
Mayo Clinic